In vitro and in vivo studies of the biological activity of novel arylimidamides against Trypanosoma cruzi

J. S. De Araújo, C. F. Da Silva, D. G.J. Batista, P. B. Da Silva, M. B. Meuser, C. A.F. Aiub, M. F.V. Da Silva, C. F. Araújo-Lima, M. Banerjee, A. A. Farahat, Chad E. Stephens, A. Kumar, D. W. Boykin, M. N.C. Soeiro

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Fifteen novel arylimidamides (AIAs) (6 bis-amidino and 9 mono-amidino analogues) were assayed against Trypanosoma cruzi in vitro and in vivo. All the bis-AIAs were more effective than the mono-AIAs, and two analogues, DB1967 and DB1989, were further evaluated in vivo. Although both of them reduced parasitemia, protection against mortality was not achieved. Our results show that the number of amidino-terminal units affects the efficacy of arylimidamides against T. cruzi.

Original languageEnglish (US)
Pages (from-to)4191-4195
Number of pages5
JournalAntimicrobial Agents and Chemotherapy
Volume58
Issue number7
DOIs
StatePublished - Jan 1 2014

Fingerprint

Trypanosoma cruzi
Parasitemia
Mortality
In Vitro Techniques

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

De Araújo, J. S., Da Silva, C. F., Batista, D. G. J., Da Silva, P. B., Meuser, M. B., Aiub, C. A. F., ... Soeiro, M. N. C. (2014). In vitro and in vivo studies of the biological activity of novel arylimidamides against Trypanosoma cruzi. Antimicrobial Agents and Chemotherapy, 58(7), 4191-4195. https://doi.org/10.1128/AAC.01403-13

In vitro and in vivo studies of the biological activity of novel arylimidamides against Trypanosoma cruzi. / De Araújo, J. S.; Da Silva, C. F.; Batista, D. G.J.; Da Silva, P. B.; Meuser, M. B.; Aiub, C. A.F.; Da Silva, M. F.V.; Araújo-Lima, C. F.; Banerjee, M.; Farahat, A. A.; Stephens, Chad E.; Kumar, A.; Boykin, D. W.; Soeiro, M. N.C.

In: Antimicrobial Agents and Chemotherapy, Vol. 58, No. 7, 01.01.2014, p. 4191-4195.

Research output: Contribution to journalArticle

De Araújo, JS, Da Silva, CF, Batista, DGJ, Da Silva, PB, Meuser, MB, Aiub, CAF, Da Silva, MFV, Araújo-Lima, CF, Banerjee, M, Farahat, AA, Stephens, CE, Kumar, A, Boykin, DW & Soeiro, MNC 2014, 'In vitro and in vivo studies of the biological activity of novel arylimidamides against Trypanosoma cruzi', Antimicrobial Agents and Chemotherapy, vol. 58, no. 7, pp. 4191-4195. https://doi.org/10.1128/AAC.01403-13
De Araújo, J. S. ; Da Silva, C. F. ; Batista, D. G.J. ; Da Silva, P. B. ; Meuser, M. B. ; Aiub, C. A.F. ; Da Silva, M. F.V. ; Araújo-Lima, C. F. ; Banerjee, M. ; Farahat, A. A. ; Stephens, Chad E. ; Kumar, A. ; Boykin, D. W. ; Soeiro, M. N.C. / In vitro and in vivo studies of the biological activity of novel arylimidamides against Trypanosoma cruzi. In: Antimicrobial Agents and Chemotherapy. 2014 ; Vol. 58, No. 7. pp. 4191-4195.
@article{c17b73c93f4b46529e679147f2ae8c2c,
title = "In vitro and in vivo studies of the biological activity of novel arylimidamides against Trypanosoma cruzi",
abstract = "Fifteen novel arylimidamides (AIAs) (6 bis-amidino and 9 mono-amidino analogues) were assayed against Trypanosoma cruzi in vitro and in vivo. All the bis-AIAs were more effective than the mono-AIAs, and two analogues, DB1967 and DB1989, were further evaluated in vivo. Although both of them reduced parasitemia, protection against mortality was not achieved. Our results show that the number of amidino-terminal units affects the efficacy of arylimidamides against T. cruzi.",
author = "{De Ara{\'u}jo}, {J. S.} and {Da Silva}, {C. F.} and Batista, {D. G.J.} and {Da Silva}, {P. B.} and Meuser, {M. B.} and Aiub, {C. A.F.} and {Da Silva}, {M. F.V.} and Ara{\'u}jo-Lima, {C. F.} and M. Banerjee and Farahat, {A. A.} and Stephens, {Chad E.} and A. Kumar and Boykin, {D. W.} and Soeiro, {M. N.C.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1128/AAC.01403-13",
language = "English (US)",
volume = "58",
pages = "4191--4195",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "7",

}

TY - JOUR

T1 - In vitro and in vivo studies of the biological activity of novel arylimidamides against Trypanosoma cruzi

AU - De Araújo, J. S.

AU - Da Silva, C. F.

AU - Batista, D. G.J.

AU - Da Silva, P. B.

AU - Meuser, M. B.

AU - Aiub, C. A.F.

AU - Da Silva, M. F.V.

AU - Araújo-Lima, C. F.

AU - Banerjee, M.

AU - Farahat, A. A.

AU - Stephens, Chad E.

AU - Kumar, A.

AU - Boykin, D. W.

AU - Soeiro, M. N.C.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Fifteen novel arylimidamides (AIAs) (6 bis-amidino and 9 mono-amidino analogues) were assayed against Trypanosoma cruzi in vitro and in vivo. All the bis-AIAs were more effective than the mono-AIAs, and two analogues, DB1967 and DB1989, were further evaluated in vivo. Although both of them reduced parasitemia, protection against mortality was not achieved. Our results show that the number of amidino-terminal units affects the efficacy of arylimidamides against T. cruzi.

AB - Fifteen novel arylimidamides (AIAs) (6 bis-amidino and 9 mono-amidino analogues) were assayed against Trypanosoma cruzi in vitro and in vivo. All the bis-AIAs were more effective than the mono-AIAs, and two analogues, DB1967 and DB1989, were further evaluated in vivo. Although both of them reduced parasitemia, protection against mortality was not achieved. Our results show that the number of amidino-terminal units affects the efficacy of arylimidamides against T. cruzi.

UR - http://www.scopus.com/inward/record.url?scp=84903219297&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903219297&partnerID=8YFLogxK

U2 - 10.1128/AAC.01403-13

DO - 10.1128/AAC.01403-13

M3 - Article

VL - 58

SP - 4191

EP - 4195

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 7

ER -